The reverse split and preferred-stock elimination are administrative clean-ups, not catalysts. Monitor the next 10-Q for any change in authorized share count or new financing activity that could dilute the now-thinner share base.
Price Chart
Executive Summary
Jaguar Health filed a Certificate of Elimination removing 14 series of preferred stock (Series B-2 through O) from its charter, as all shares had been previously converted, exchanged, or disposed of. The company also effected a 1-for-15 reverse stock split on September 17, 2026, reducing outstanding common shares to approximately 520,088. These are routine capital structure clean-up actions with no immediate financial impact.
Key Facts
- Certificate of Elimination filed September 15, 2026 for 14 series of preferred stock (Series B-2 through O)
- No shares of any eliminated preferred series were outstanding prior to filing
- 1-for-15 reverse stock split effected September 17, 2026
- Post-split outstanding common shares: approximately 520,088
Financial Impact
No financial figures provided; reverse split is a mechanical share consolidation with no change to aggregate market value
Risk Factors
- Post-split float of ~520K shares is extremely thin, increasing price volatility
- Reverse splits often precede dilutive financings in micro-cap biotechs
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-396752 |
| Document: d79729dex31.htm | 0001193125-26-396752 |
| Document: 0001193125-26-396752-index-headers.html | 0001193125-26-396752 |
| Document: 0001193125-26-396752-index.html | 0001193125-26-396752 |
| Document: 0001193125-26-396752.txt | 0001193125-26-396752 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | S-3 | $2.04 | awaiting T+60 | — | $2.18 (−6.86%) |
Oct 8, 2026 18d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.18 (+54.49%) |
Oct 5, 2026 22d ago | 8-K | $4.73 | awaiting T+60 | — | $2.18 (+53.91%) |
Sep 28, 2026 29d ago | 8-K | $6.02 | awaiting T+60 | — | $2.18 (+63.79%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.18 (+71.69%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.18 (+69.12%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.18 (+69.12%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.18 (−93.67%) |
Sep 15, 2026 5w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.18 (−870.61%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.18 (+79.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers